Oncotype DX is a clinically validated multigene assay for predicting the likely benefit of chemotherapy in this patient population and is uniquely available from the current supplier on the global market.
Scadenza
30.06.2026
Pubblicazione
26.10.2026
Aggiudicata
26.10.2026
Preliminary Market Engagement for Real Time Location System (
Aperta alle offerte·Oct 19
Purchase of lightsouce
Aggiudicata·Oct 16
Purchase of Cardiotocography machines
Aggiudicata·Oct 12
Purchase of ENT Microscopes
Aggiudicata·Oct 7
Rental of 1 x Interventional Radiology Suite
Aggiudicata·Oct 6
Linen & Laundry - Managed Services
Aggiudicata·Sep 29
Histology Reporting
Aggiudicata·Oct 14
WSFT - Pathology - Bloodtrack software support
Aggiudicata·Oct 9
WSFT - Pathology - AlinIQ Indexor
Aggiudicata·Oct 9
WSFT - Pathology - Bloodtrack software support
Aggiudicata·Oct 1
WSFT - Managed Service - Pathology - Microbiology testing Pro-Lab Diagnostics
Aggiudicata·Sep 4
Pathology Managed Service for Midlands & East 2 Network
Aggiudicata·Jul 10
Infrastructure Connection Design Support - Pathology Lab
Aggiudicata·Oct 30
Provision of Pre-Paid Cards
Aggiudicata·Oct 30
7.5t Isuzu Repower (Electrification) 7.5t Isuzu with NTM Polybody Refurbishment
Aggiudicata·Oct 30
Business Travel Services
Aggiudicata·Oct 30
Call-Off : GLCCA Project, Programme and Portfolio Management Solution
Aggiudicata·Oct 30
QLT354 2026-10-29 (0900) Leiston - Roman Hill Primary School, Lowestoft (8 seats and a PA) - AWARD
Aggiudicata·Oct 30
Crei un account per approfondire questa gara e trovare opportunità simili.